Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease

被引:0
|
作者
Samaa Shama
Wanqing Liu
机构
[1] Wayne State University,Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences
[2] Wayne State University,Department of Pharmacology, School of Medicine
[3] National Organization of Drug Control and Research,Department of Molecular Drug Evaluation
[4] Wayne State University,iBio Center 2401
来源
关键词
Gut microbiota; NAFLD; Nutrient; n-3/n-6 PUFA;
D O I
暂无
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease characterized with the spectrum of hepatic steatosis, inflammation, and fibrosis. The etiology of NAFLD remains incompletely understood. Numerous studies have implied that the gut microbiota (GM) is involved in the development of NAFLD, as it particularly mediating the interaction between nutrient intake and the gut–liver function. Meanwhile, the omega-3 and omega-6 polyunsaturated fatty acids (n-3/n-6 PUFA) as essential fatty acids have been linked to NAFLD. Increasing studies in the past decades have indicated that there is a reciprocal interaction between GM and n-3/n-6 PUFA, which may be underlying at least in part, the pathogenesis of NAFLD. In this review, we will discuss: (1) How GM is linked to NAFLD by interacting with various nutrients; (2) How imbalanced dietary n-3/n-6 PUFA is linked to NAFLD; (3) How n-3/n-6 PUFA may affect the GM balance, leading to altered nutrients release to the liver; and (4) How GM may modify ingested n-3/n-6 PUFA and alter their absorption, bioavailability, and biotransformation.
引用
收藏
页码:906 / 910
页数:4
相关论文
共 50 条
  • [1] Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease
    Shama, Samaa
    Liu, Wanqing
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (03) : 906 - 910
  • [2] Correction to: Omega‑3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease
    Samaa Shama
    Wanqing Liu
    Digestive Diseases and Sciences, 2020, 65 : 1556 - 1556
  • [3] Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease (vol 65, pg 906, 2020)
    Shama, Samaa
    Liu, Wanqing
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (05) : 1556 - 1556
  • [4] Exercise and Omega-3 Fatty Acids as Treatments for Nonalcoholic Fatty Liver Disease
    Borengasser, Sarah
    Rector, R. Scott
    Uptergrove, Grace
    Morris, E. Matthew
    Booth, Frank
    Fritsche, Kevin
    Ibdah, Jamal
    Thyfault, John
    DIABETES, 2010, 59 : A412 - A412
  • [5] Impact of Omega-3 Fatty Acids on the Gut Microbiota
    Costantini, Lara
    Molinari, Romina
    Farinon, Barbara
    Merendino, Nicolo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [6] Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use
    Spooner, Melinda H.
    Jump, Donald B.
    ANNUAL REVIEW OF NUTRITION, 2023, 43 : 199 - 223
  • [7] Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
    Jump, Donald B.
    Lytle, Kelli A.
    Depner, Christopher M.
    Tripathy, Sasmita
    PHARMACOLOGY & THERAPEUTICS, 2018, 181 : 108 - 125
  • [8] Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
    Scorletti, E.
    Byrne, C. D.
    ANNUAL REVIEW OF NUTRITION, VOL 33, 2013, 33 : 231 - 248
  • [9] Omega-3 fatty acids and metabolic partitioning of fatty acids within the liver in the context of nonalcoholic fatty liver disease
    Calder, Philip C.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2022, 25 (04): : 248 - 255
  • [10] Omega-3 fatty acids for the treatment of nonalcoholic fatty liver disease in children and adolescents
    Athyros, Vasilios G.
    Mikhailidis, Dimitri P.
    CLINICAL LIPIDOLOGY, 2013, 8 (05) : 509 - 512